{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:34:34Z","timestamp":1768523674033,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":4824,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1093\/annonc\/mdl163","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:59:24Z","timestamp":1156546764000},"page":"1512-1516","source":"Crossref","is-referenced-by-count":39,"title":["Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"G.","family":"Sanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Preda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bruschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cossu Rocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Adamoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Franceschelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nol\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1093\/annonc\/mdl163_bb0010","article-title":"Update on the role of bisphosphonates in metastatic breast cancer","volume":"28","author":"Lipton","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0015","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.1998.16.12.3890","article-title":"International Bone and Cancer Study Group. Current use of bisphosphonates in oncology","volume":"16","author":"Body","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0020","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology Bisphosphonates Expert Panel. American Society of Clinical Oncology Clinical Practice Guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0025","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hilner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0030","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surgery"},{"issue":"7","key":"10.1093\/annonc\/mdl163_bb0040","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/annonc\/mdi206","article-title":"Jaw avascular bone necrosis associated with long-term use of biphosphonates","volume":"16","author":"Sanna","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl163_bb0050","unstructured":"Oncology Drugs Advisory Committee, Novartis Pharmaceuticals, March 4, 2005."},{"key":"10.1093\/annonc\/mdl163_bb0055","series-title":"Expert panel recommendations for the prevention, diagnosis and treatment of osteonecrosis of the jaws","author":"Damato","year":"2004"},{"key":"10.1093\/annonc\/mdl163_bb0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular bone necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1093\/annonc\/mdl163_bb0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl163_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of ostenecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Practice"},{"key":"10.1093\/annonc\/mdl163_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and ostenecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endotol"},{"key":"10.1093\/annonc\/mdl163_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.joms.2003.11.009","article-title":"New foundations in understanding osteonecrosis of the jaws","volume":"62","author":"Assael","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1093\/annonc\/mdl163_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002560050028","article-title":"CT findings in osteoradionecrosis of the mandible","volume":"25","author":"Hermans","year":"1996","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1093\/annonc\/mdl163_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5694\/j.1326-5377.2005.tb06970.x","article-title":"Bisphosphonates and osteonecrosis: analogy to phossi jaw","volume":"183","author":"Donoghue","year":"2005","journal-title":"Med J Aust"},{"key":"10.1093\/annonc\/mdl163_bb0095","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st Century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1093\/annonc\/mdl163_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdl045","article-title":"Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?","author":"Ardine","year":"2006","journal-title":"Ann Oncol"},{"issue":"suppl. 4","key":"10.1093\/annonc\/mdl163_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: Preclinical Review","volume":"9","author":"Green","year":"2004","journal-title":"The Oncologist"},{"key":"10.1093\/annonc\/mdl163_bb0110","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdl163_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.STR.0000110789.20526.9D","article-title":"Periodontal disease as a risk factor for ischemic stroke","volume":"35","author":"Grau","year":"2004","journal-title":"Stroke"},{"key":"10.1093\/annonc\/mdl163_bb0120","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/jcb.240550303","article-title":"Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone","volume":"55","author":"Parfitt","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.1093\/annonc\/mdl163_bb0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419473274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419473274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/10\/1512\/650586\/mdl163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T11:47:28Z","timestamp":1582199248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419473274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0923753419473274"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl163","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}